News & TMS Insights
Dr. Shan Siddiqi discusses standardizing brain stimulation training to create a new accredited subspecialty, enhancing cross-disciplinary...
FDA clears neurocare group's Apollo TMS Therapy for adolescent depression, offering a safe, non-invasive alternative to traditional...
Leadership continuity positions neurocare for its next decade of global expansion, innovation, and patient impact.
Can TMS therapy for depression be delivered in a single day? Dr. Jonathan Downar discusses the promising results of the ONE-D Trial.